Patrik Sobocki

Summary

Affiliation: Stockholm Health Economics
Country: Sweden

Publications

  1. ncbi The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression
    P Sobocki
    Department of Learning, Informatics, Management and Ethics, Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
    Int J Clin Pract 60:791-8. 2006
  2. ncbi Model to assess the cost-effectiveness of new treatments for depression
    Patrik Sobocki
    Department of Learning, Informatics, Management and Ethics, Karolinska Institutet and European Health Economics AB, Stockholm, Sweden
    Int J Technol Assess Health Care 22:469-77. 2006
  3. ncbi Cost of depression in Europe
    Patrik Sobocki
    Medical Management Centre, Department of Learning Informatics Management and Ethics, Karolinska Institutet, Stockholm, Sweden
    J Ment Health Policy Econ 9:87-98. 2006
  4. ncbi Resource allocation to brain research in Europe (RABRE)
    P Sobocki
    Karolinska Institutet, Stockholm, Sweden
    Eur J Neurosci 24:2691-3. 2006
  5. ncbi Health-related quality of life measured with EQ-5D in patients treated for depression in primary care
    Patrik Sobocki
    Karolinska Institutet, Stockholm, Sweden
    Value Health 10:153-60. 2007
  6. ncbi The societal burden of osteoporosis in Sweden
    Fredrik Borgstrom
    European Health Economics, Stockholm, Sweden
    Bone 40:1602-9. 2007
  7. ncbi The economic burden of depression in Sweden from 1997 to 2005
    Patrik Sobocki
    Division for International Health IHCAR, Karolinska Institutet, Stockholm, Sweden
    Eur Psychiatry 22:146-52. 2007
  8. ncbi Economic evaluations of leukemia: a review of the literature
    Frida Kasteng
    European Health Economics, Vasagatan 38, Stockholm 111 20, Sweden
    Int J Technol Assess Health Care 23:43-53. 2007
  9. doi Cost of disorders of the brain in Italy
    Maura Pugliatti
    Dipartimento di Neuroscienze e Scienze Materno Infantili, Universita di Sassari, Viale San Pietro 10, 07100, Sassari, Italy
    Neurol Sci 29:99-107. 2008
  10. ncbi Estimating the cost of epilepsy in Europe: a review with economic modeling
    Maura Pugliatti
    Institute of Clinical Neurology, Medical School, University of Sassari, Sassari, Italy
    Epilepsia 48:2224-33. 2007

Detail Information

Publications15

  1. ncbi The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression
    P Sobocki
    Department of Learning, Informatics, Management and Ethics, Medical Management Centre, Karolinska Institutet, Stockholm, Sweden
    Int J Clin Pract 60:791-8. 2006
    ..01). We conclude that remission has a substantial health economic impact on patients treated for depression, which further strengthens the importance of aiming for full remission in the treatment of depression...
  2. ncbi Model to assess the cost-effectiveness of new treatments for depression
    Patrik Sobocki
    Department of Learning, Informatics, Management and Ethics, Karolinska Institutet and European Health Economics AB, Stockholm, Sweden
    Int J Technol Assess Health Care 22:469-77. 2006
    ..The objective of this study was to develop a model to assess the cost-effectiveness of a new treatment for patients with depression...
  3. ncbi Cost of depression in Europe
    Patrik Sobocki
    Medical Management Centre, Department of Learning Informatics Management and Ethics, Karolinska Institutet, Stockholm, Sweden
    J Ment Health Policy Econ 9:87-98. 2006
    ..Yet, the knowledge of the economic impact of depression has been relatively little researched in Europe...
  4. ncbi Resource allocation to brain research in Europe (RABRE)
    P Sobocki
    Karolinska Institutet, Stockholm, Sweden
    Eur J Neurosci 24:2691-3. 2006
    ..We conclude that European spending on brain research, particularly public spending, is low compared to other fields of research and to the US, and that increased investment in brain research seems warranted...
  5. ncbi Health-related quality of life measured with EQ-5D in patients treated for depression in primary care
    Patrik Sobocki
    Karolinska Institutet, Stockholm, Sweden
    Value Health 10:153-60. 2007
    ..The objective of the present study was to assess the impact of depression on patients' health-related quality of life (HRQL) with the EQ-5D instrument over 6 months while on antidepressant treatment...
  6. ncbi The societal burden of osteoporosis in Sweden
    Fredrik Borgstrom
    European Health Economics, Stockholm, Sweden
    Bone 40:1602-9. 2007
    ..This burden is substantial and must be acknowledged as an important health problem. Osteoporosis-related fractures do not only lead to high medical care costs but also to high community care costs...
  7. ncbi The economic burden of depression in Sweden from 1997 to 2005
    Patrik Sobocki
    Division for International Health IHCAR, Karolinska Institutet, Stockholm, Sweden
    Eur Psychiatry 22:146-52. 2007
    ..The aim of this study was to estimate the economic burden of depression to Swedish society from 1997 to 2005...
  8. ncbi Economic evaluations of leukemia: a review of the literature
    Frida Kasteng
    European Health Economics, Vasagatan 38, Stockholm 111 20, Sweden
    Int J Technol Assess Health Care 23:43-53. 2007
    ..More information about the total costs, that is, including indirect costs, and quality of life effects would be valuable in future evaluations in leukemia...
  9. doi Cost of disorders of the brain in Italy
    Maura Pugliatti
    Dipartimento di Neuroscienze e Scienze Materno Infantili, Universita di Sassari, Viale San Pietro 10, 07100, Sassari, Italy
    Neurol Sci 29:99-107. 2008
    ..This figure is however likely to be underestimated as it is based on retrospective methodology and samples of brain disorders, and does not include intangible costs...
  10. ncbi Estimating the cost of epilepsy in Europe: a review with economic modeling
    Maura Pugliatti
    Institute of Clinical Neurology, Medical School, University of Sassari, Sassari, Italy
    Epilepsia 48:2224-33. 2007
    ..Based on available epidemiologic, health economic, and international population statistics literature, the cost of epilepsy in Europe was estimated...
  11. ncbi Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
    Gisela Kobelt
    Department of Orthopedics, University of Lund, Sweden gisela
    Int J Technol Assess Health Care 23:368-75. 2007
    ..To compare the cost-effectiveness of the treatment of ankylosing spondylitis (AS) with infliximab in the United Kingdom over lifetime estimated from two different clinical trials and adjusted for clinical practice guidelines...
  12. ncbi [High societal costs of brain diseases. Extremely small resources allocated to research on prevention and treatment]
    Patrik Sobocki
    Institutionen för folkhälsovetenskap
    Lakartidningen 104:1590-4. 2007
  13. ncbi Cost estimates of brain disorders in Belgium
    Jean Schoenen
    Department of Neurology Headache Research Unit and Research Center for Cellular and Molecular Neurobiology, University of Liege, Liege, Belgium
    Acta Neurol Belg 106:208-14. 2006
    ..Such a survey is being organized by a task force of the Belgian Brain Council...
  14. doi The burden of ankylosing spondylitis in Spain
    Gisela Kobelt
    Lund University, Sweden and European Health Economics, Mulhouse, France
    Value Health 11:408-15. 2008
    ..To investigate the burden of ankylosing spondylitis (AS) in Spain, as baseline for economic evaluation of the use of biological agents...
  15. doi Cost of disorders of the brain in Switzerland with a focus on mental disorders
    Matthias Jäger
    Department of General and Social Psychiatry, University of Zurich, Zurich, Switzerland
    Swiss Med Wkly 138:4-11. 2008
    ..This study aims at estimating the costs of disorders of the brain in Switzerland based on the published epidemiological and economic evidence...